These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31784186)

  • 1. Fangchinoline derivatives induce cell cycle arrest and apoptosis in human leukemia cell lines via suppression of the PI3K/AKT and MAPK signaling pathway.
    Yang J; Hu S; Wang C; Song J; Chen C; Fan Y; Ben-David Y; Pan W
    Eur J Med Chem; 2020 Jan; 186():111898. PubMed ID: 31784186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 4-aminoquinazoline derivatives induce growth inhibition, cell cycle arrest and apoptosis via PI3Kα inhibition.
    Fan YH; Ding HW; Liu DD; Song HR; Xu YN; Wang J
    Bioorg Med Chem; 2018 May; 26(8):1675-1685. PubMed ID: 29475582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fangchinoline derivatives inhibits PI3K signaling in vitro and in vivo in non-small cell lung cancer.
    Chen JS; Guo X; Sun JY; Wang MX; Gao XZ; Wang Z; Han JL; Sun H; Zhang K; Liu C
    Bioorg Chem; 2023 Sep; 138():106623. PubMed ID: 37295240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
    Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
    Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells.
    Tian F; Ding D; Li D
    Int J Oncol; 2015; 46(6):2355-63. PubMed ID: 25872479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives.
    Gao XZ; Lv XT; Zhang RR; Luo Y; Wang MX; Chen JS; Zhang YK; Sun B; Sun JY; Liu YF; Liu C
    Bioorg Chem; 2021 Apr; 109():104694. PubMed ID: 33601141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
    Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel derivative of valepotriate inhibits the PI3K/AKT pathway and causes Noxa-dependent apoptosis in human pancreatic cancer cells.
    Yan YY; Shi KY; Teng F; Chen J; Che JX; Dong XW; Lin NM; Zhang B
    Acta Pharmacol Sin; 2020 Jun; 41(6):835-842. PubMed ID: 32047260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 1-(3-aryl-4-chlorophenyl)-3-(p-aryl)urea derivatives against breast cancer by inhibiting PI3K/Akt/mTOR and Hedgehog signalings.
    Li W; Sun Q; Song L; Gao C; Liu F; Chen Y; Jiang Y
    Eur J Med Chem; 2017 Dec; 141():721-733. PubMed ID: 29107429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and in vitro evaluation of fangchinoline derivatives as potential anticancer agents.
    Zhang YC; Gao XZ; Liu C; Wang MX; Zhang RR; Sun JY; Liu YF
    Bioorg Chem; 2020 Jan; 94():103431. PubMed ID: 31759658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzo[b]furan derivatives induces apoptosis by targeting the PI3K/Akt/mTOR signaling pathway in human breast cancer cells.
    Kamal A; Lakshma Nayak V; Nagesh N; Vishnuvardhan MV; Subba Reddy NV
    Bioorg Chem; 2016 Jun; 66():124-31. PubMed ID: 27149364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis of Novel Tetrandrine-14-l-Amino Acid and Tetrandrine-14-l-Amino Acid-Urea Derivatives as Potential Anti-Cancer Agents.
    Hu SC; Yang J; Chen C; Song JR; Pan WD
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32283819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural optimization elaborates novel potent Akt inhibitors with promising anticancer activity.
    Liu Y; Yin Y; Zhang Z; Li CJ; Zhang H; Zhang D; Jiang C; Nomie K; Zhang L; Wang ML; Zhao G
    Eur J Med Chem; 2017 Sep; 138():543-551. PubMed ID: 28704757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological activities of tetrandrine and fangchinoline derivatives as antitumer agents.
    Li D; Liu H; Liu Y; Zhang Q; Liu C; Zhao S; Jiao B
    Bioorg Med Chem Lett; 2017 Feb; 27(3):533-536. PubMed ID: 28057423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Bromophenol Derivative BOS-102 Induces Cell Cycle Arrest and Apoptosis in Human A549 Lung Cancer Cells via ROS-Mediated PI3K/Akt and the MAPK Signaling Pathway.
    Guo CL; Wang LJ; Zhao Y; Liu H; Li XQ; Jiang B; Luo J; Guo SJ; Wu N; Shi DY
    Mar Drugs; 2018 Jan; 16(2):. PubMed ID: 29370087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,4-Disubstituted quinazolines targeting breast cancer cells via EGFR-PI3K.
    Li ED; Lin Q; Meng YQ; Zhang LY; Song PP; Li N; Xin JC; Yang P; Bao CN; Zhang DQ; Zhang Y; Wang JK; Zhang QR; Liu HM
    Eur J Med Chem; 2019 Jun; 172():36-47. PubMed ID: 30939352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on MAPK/ERK and CDK2-Cyclin-E signal switch "on and off" in cell proliferation by bis urea derivatives of 1, 4-Diisocyanatobenzene.
    Nagalakshmamma V; Venkataswamy M; Pasala C; Uma Maheswari A; Thyaga Raju K; Nagaraju C; Chalapathi PV
    Bioorg Chem; 2021 Jul; 112():104940. PubMed ID: 33965780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.